Practice Updates: Postpartum Hemorrhage, Updated Zika Practice Advisory


Stay up to date with ACOG's authoritative clinical guidance and helpful patient education materials. The following provides Practice Updates for September and October 2017. 

TOPIC SPOTLIGHT

Featured Practice Bulletin 183: Postpartum Hemorrhage

ACOG expanded its guidance on postpartum hemorrhage to include recommendations for standard, hospital-wide protocols, as well as potential treatments. ACOG recommends that all hospitals put organized, systematic processes in place to help coordinate the response and management of postpartum hemorrhage. Multidisciplinary teams, including physicians, nurses and midwives, should be trained to implement key elements in four categories, including readiness to respond; recognition and prevention measures; multidisciplinary response; and data reporting and systematic learning, including drills like simulation-based training.

Practice Bulletin 183: Postpartum Hemorrhage is available in the October 2017 issue of Obstetrics & Gynecology.


Featured Practice Advisory: Interim Guidance for Care of Obstetrics Patients During a Zika Virus Outbreak

Updated September 13, 2017, critical updates to the Zika Practice Advisory from ACOG and the Society for Maternal-Fetal Medicine include recommendations from the Centers for Disease Control and Prevention (CDC). The CDC no longer recommends routine Zika virus testing for asymptomatic pregnant women with possible Zika exposure that is not ongoing*. Some jurisdictions (e.g. those at increased risk for local transmission) will continue to recommend Zika testing for asymptomatic pregnant women due to increased risks of transmission. Obstetric providers should check regularly with their state and local health departments for information on testing asymptomatic pregnant women without ongoing* possible exposure.

*Ongoing exposure is defined as currently living in or frequent travel (e.g. daily or weekly) to areas with Zika virus transmission

Regardless of location, providers should evaluate all pregnant women in the United States for possible Zika virus exposure during each prenatal care visit. This evaluation should include an assessment of signs and symptoms of Zika virus disease, a travel history, and a woman's sexual partner's potential exposure.

Read the full Practice Advisory,Interim Guidance for Care of Obstetrics Patients During a Zika Virus Outbreak, updated September 13, 2017

 

Zika Information

ACOG’s Zika webpage

ACOG Zika Toolkit, including patient education video, infographic, and assessment web tool endorsed by CDC

CDC’s Pregnancy and Zika Testing Clinical Algorithm

CDC Zika Virus Website

State Health Department Contact list for ob-gyns (members only) for questions on CDC's Zika Registry and testing

CDC Zika Pregnancy Hotline for Health Care Providers: Ob-gyns can contact the CDC Zika Pregnancy Hotline at 770-488-7100, or email ZikaPregnancy@cdc.gov for any concerns related to clinical management or the US Zika Pregnancy Registry

Office of Population Affairs' Zika Toolkit


LIST OF NEW PRACTICE PUBLICATIONS OCTOBER 2017

New Committee Opinions

See all Committee Opinions

                                                                                                                                  

New Practice Bulletins (members only)

See all Practice Bulletins

 

New Title: Clinical Updates in Women's Health Care (members only)

See all Clinical Updates Titles

 

New & Recently Updated Patient Education Pamphlets (members only)

See all Patient Education Pamphlets


Frequently Asked Questions (FAQs) for Patients

See all Frequently Asked Questions

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998